GlassScriptPhysician profile
Mark F Picone
NPI 1538169644
$9,405.78
in general payments reported to CMS, 2019-2025
32 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,022 · 2020: $1,082 · 2021: $1,154 · 2022: $990 · 2023: $1,387 · 2024: $1,625 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,157.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,769.24 | 2019-2024 | Ultreon, Coroflow, Mitraclip |
| Abiomed | $1,942.52 | 2019-2024 | Impella |
| Amgen INC. | $1,113.49 | 2019-2024 | Repatha |
| Boston Scientific Corporation | $865.09 | 2019-2024 | Comet |
| Shockwave Medical, INC | $446.93 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Actelion Pharmaceuticals US, INC. | $413.55 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $257.96 | 2019-2024 | Xarelto |
| Medtronic, INC. | $223.77 | 2021-2025 | Corevalve Evolut R, Venaseal |
| Penumbra, INC. | $209.33 | 2024 | Indigo System |
| Acist Medical Systems, INC. | $204.40 | 2021-2024 | |
| Inari Medical, INC. | $199.32 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cvrx, INC. | $146.36 | 2023-2024 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $99.20 | 2021-2024 | |
| Pfizer INC. | $69.62 | 2019-2024 | |
| Edwards Lifesciences Corporation | $64.91 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $55.29 | 2023 | Optimizer |
| Novo Nordisk INC | $46.91 | 2024 | Ozempic |
| Philips North America LLC | $38.97 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $33.42 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $32.60 | 2022-2023 | Eliquis |
| Chiesi USA, INC. | $28.26 | 2020-2021 | |
| Terumo Medical Corporation | $27.62 | 2020 | |
| Medtronic Vascular, INC. | $24.46 | 2019 | |
| Teleflex LLC | $21.79 | 2021 | |
| Cardiva Medical, INC. | $16.86 | 2020 | |
| Angiodynamics, INC. | $15.33 | 2020 | |
| Tactile Systems Technology INC | $13.37 | 2024 | Entre Plus, Flexitouch Plus |
| Ekos Corporation | $13.08 | 2019 | |
| Cardiovascular Systems INC. | $12.13 | 2020 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Picone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.